Physician profile
Benjamin Cable
NPI 1437134210
$895.12
in general payments reported to CMS, 2019-2025
9 companies · $609 in 2025
The $609 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $19.73 · 2024: $267 · 2025: $609.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $254.03 | 2024-2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Neurent Medical Limited | $229.94 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark System, Neuromark Device |
| Genzyme Corporation | $123.40 | 2025 | |
| Aerin Medical INC. | $81.34 | 2024-2025 | |
| Medtronic, INC. | $75.43 | 2024 | Propel |
| Karl Storz Endoscopy-America | $51.93 | 2025 | N.A. |
| Boston Scientific Corporation | $39.58 | 2025 | General - Kidney Stone Disease |
| Ars Pharmaceuticals Operations, INC. | $19.74 | 2025 | Neffy |
| Acclarent, INC | $19.73 | 2023 | Trudi Nav Cable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Cable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.